TY  - RPRT
TI  - TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy
AU  - Ruitao Lin
AU  - Robert L Coleman
AU  - Ying Yuan
PY  - 2018
UR  - https://arxiv.org/abs/1810.00709
ID  - 1810.00709
ER  -